Your browser doesn't support javascript.
loading
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.
Garfall, Alfred L; Cohen, Adam D; Susanibar-Adaniya, Sandra P; Hwang, Wei-Ting; Vogl, Dan T; Waxman, Adam J; Lacey, Simon F; Gonzalez, Vanessa E; Fraietta, Joseph A; Gupta, Minnal; Kulikovskaya, Irina; Tian, Lifeng; Chen, Fang; Koterba, Natalka; Bartoszek, Robert L; Patchin, Margaret; Xu, Rong; Plesa, Gabriela; Siegel, Don L; Brennan, Andrea; Nelson, Anne Marie; Ferthio, Regina; Cosey, Angela; Shea, Kim-Marie; Leskowitz, Rachel; Four, Megan; Wilson, Wesley V; Miao, Fei; Lancaster, Eric; Carreno, Beatriz M; Linette, Gerald P; Hexner, Elizabeth O; Young, Regina M; Bu, Dexiu; Mansfield, Keith G; Brogdon, Jennifer L; June, Carl H; Milone, Michael C; Stadtmauer, Edward A.
Afiliación
  • Garfall AL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Susanibar-Adaniya SP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hwang WT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Vogl DT; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Waxman AJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lacey SF; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gonzalez VE; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fraietta JA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gupta M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kulikovskaya I; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Tian L; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Chen F; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Koterba N; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bartoszek RL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Patchin M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Xu R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Plesa G; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Siegel DL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Brennan A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nelson AM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ferthio R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Cosey A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shea KM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Leskowitz R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Four M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Wilson WV; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Miao F; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lancaster E; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Carreno BM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Linette GP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hexner EO; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Young RM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bu D; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Mansfield KG; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Brogdon JL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Milone MC; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Stadtmauer EA; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Blood Cancer Discov ; 4(2): 118-133, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36413381
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Límite: Humans Idioma: En Revista: Blood Cancer Discov Año: 2023 Tipo del documento: Article